Clinical trial
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With…
NCT00327015 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00327015 |
|---|---|
| Title | A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise |
| Official title | A Multicenter, Randomized, Double-Blind Active-Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR as Initial Therapy Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate… |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes |
| Intervention type | Drug |
| Interventions | Saxagliptin, Metformin, Placebo, pioglitazone |
| Enrollment | 1,306 |
| Start date | May 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Dec 1, 2008 |
| First posted | May 17, 2006 |
| Last update posted | Apr 29, 2015 |
| Countries | Argentina, Brazil, Germany, Hungary, India, Italy, Mexico, Philippines, Poland, Puerto Rico, Russia, Ukraine and 1 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: